Since COX-2 overexpression was also shown in cancer and is assumed to be implicated in inflammogenesis of cancer [11,17,18,19,20,21,22,23,24], it came more and more in the focus as a diagnostic marker and therapeutic target in oncology. Here, PTGS2 is linked to cancer.